The document discusses various minimally invasive treatment options for benign prostatic hyperplasia (BPH) including prostatic stents, transurethral needle ablation of the prostate (TUNA), transurethral microwave thermotherapy (TUMT), laser therapies such as greenlight laser, transurethral vaporization of the prostate (TUVP), and transurethral incision of the prostate (TUIP). These procedures provide improvements in urinary flow and symptom scores comparable to traditional open prostatectomy but with reduced risks of complications like bleeding, erectile dysfunction, and incontinence.